Amino acid alterations and encephalopathy in the sepsis syndrome.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 2055050)

Published in Crit Care Med on June 01, 1991

Authors

C L Sprung1, F B Cerra, H R Freund, R M Schein, F N Konstantinides, E H Marcial, M Pena

Author Affiliations

1: Hadassah University Hospital, Jerusalem, Israel.

Articles by these authors

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 47.46

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25

Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25

Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med (1995) 3.19

Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA (1997) 3.11

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84

Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA (1994) 2.71

Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet (1979) 2.71

Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med (1995) 2.63

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48

Water-soluble contrast material has no therapeutic effect on postoperative small-bowel obstruction: results of a prospective, randomized clinical trial. Am J Surg (1996) 2.47

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37

Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24

Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial. Ann Surg (1991) 2.21

Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04

The effect of intranasal fentanyl on the emergence characteristics after sevoflurane anesthesia in children undergoing surgery for bilateral myringotomy tube placement. Anesth Analg (2001) 1.69

Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med (1989) 1.62

Physiological and metabolic correlations in human sepsis. Invited commentary. Surgery (1979) 1.58

Progressive necrotizing surgical infections--a unified approach. J Trauma (1981) 1.51

Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51

The use of a disposable laparoscopic trocar for the injection and safe evacuation of echinococcus cysts of the liver. Surg Gynecol Obstet (1993) 1.48

Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg (1994) 1.46

Fulminant hepatic failure from a sea anemone sting. Ann Intern Med (1994) 1.43

Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. JPEN J Parenter Enteral Nutr (1995) 1.43

Urinary urea nitrogen: too insensitive for calculating nitrogen balance studies in surgical clinical nutrition. JPEN J Parenter Enteral Nutr (1991) 1.42

Prior healthcare utilization as a predictor of survival for medical intensive care unit patients. Crit Care Med (2000) 1.42

Paracecal hernia: a cause of intestinal obstruction. Dis Colon Rectum (1986) 1.41

How conservatively can postoperative small bowel obstruction be treated? Am J Surg (1993) 1.39

Laparoscopic splenectomy for immune thrombocytopenic purpura. J Laparoendosc Surg (1996) 1.39

The hepatic failure of sepsis: cellular versus substrate. Surgery (1979) 1.32

Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest (1997) 1.29

Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg (1978) 1.29

Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Antimicrob Agents Chemother (1981) 1.27

Hypermetabolism, organ failure, and metabolic support. Surgery (1987) 1.26

Electrophysiological evidence for automatic phonetic processing in neonates. Neuroreport (2001) 1.25

ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24

Late development of hydrothorax and hydromediastinum in patients with central venous catheters. Crit Care Med (1982) 1.23

Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1998) 1.22

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis (1996) 1.21

Branched chains support postoperative protein synthesis. Surgery (1982) 1.18

Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis. Infect Immun (1985) 1.16

Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. JPEN J Parenter Enteral Nutr (1993) 1.14

Septic autocannibalism. A failure of exogenous nutritional support. Ann Surg (1980) 1.13

Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer (2006) 1.12

Mode of physical activity and self-efficacy in older adults: a latent growth curve analysis. J Gerontol B Psychol Sci Soc Sci (1999) 1.11

Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids. In Vitro Cell Dev Biol Anim (1996) 1.11

Evolution of the bioartificial liver: the need for randomized clinical trials. Am J Surg (1993) 1.11

Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress. Ann Surg (1984) 1.07

The systemic septic response: does the organism matter? Crit Care Med (1980) 1.07

Nitrogen-sparing mechanisms of singly administered branched-chain amino acids in the injured rat. Surgery (1981) 1.06

Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun (1995) 1.04

Hemodynamic, respiratory, and metabolic effects of laparoscopic cholecystectomy. Am J Surg (1993) 1.03

The prick test and specific IgE (RAST and MAST-CLA) compared with the oral challenge test with milk, eggs and nuts. J Investig Allergol Clin Immunol (1995) 1.03

Metabolism during hepatic transplantation: indicators of allograft function. Surgery (1984) 1.02

Bacterial wall lipopolysaccharide as a cause of intussusception in mice. J Pediatr Gastroenterol Nutr (1998) 1.01

A model for reimplantation and transplantation of a complex organ: the rat hind limb. J Surg Res (1978) 1.01

Paranasal sinusitis: a common complication of nasotracheal intubation in neurosurgical patients. Neurosurgery (1985) 1.00

Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res (1991) 0.99

Multiple systems organ failure: I. The basal state. J Trauma (1981) 0.99

Regulation of murine splenocyte responses by heparan sulfate. J Immunol (1991) 0.99

Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery (1988) 0.99

Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng (1996) 0.99

Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res (1995) 0.98

Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res (1992) 0.97

Correlations between metabolic and cardiopulmonary measurements in patients after trauma, general surgery, and sepsis. J Trauma (1979) 0.97

Factors affecting the morbidity of colostomy closure: a retrospective study. Dis Colon Rectum (1982) 0.96

Endotoxin modulation of hepatocyte secretory and cellular protein synthesis is mediated by Kupffer cells. Arch Surg (1988) 0.96

Experience with the one-stage perineal repair of rectal prolapse. Dis Colon Rectum (1983) 0.95

Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant (1995) 0.95

Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients. Antimicrob Agents Chemother (1982) 0.95

Modulation of macrophage and B cell function by glycosaminoglycans. J Leukoc Biol (1999) 0.94

Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng (1993) 0.94

Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? Am J Surg (1981) 0.93

Nitrogen retention in critically ill patients is proportional to the branched chain amino acid load. Crit Care Med (1983) 0.93

Evidence based critical care medicine; what is it and what can it do for us? Evidence Based Medicine in Critical Care Group. Crit Care Med (1996) 0.92

Cancellation in elective orthopaedic surgery. Health Trends (1991) 0.92

Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody. Arch Surg (1985) 0.92

Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver. Cell Biol Toxicol (1997) 0.92

Multiple systems organ failure. Modulation of hepatocyte protein synthesis by endotoxin activated Kupffer cells. Ann Surg (1985) 0.91

The effect of dietary glutamine and dietary RNA on ileal flora, ileal histology, and bacterial translocation in mice. Nutrition (1992) 0.91

Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. Surgery (1985) 0.90

Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm (1987) 0.90

The effect on survival of critically ill and injured patients of an ICU teaching service organized about a computer-based physiologic CARE system. J Trauma (1980) 0.90

Dietary omega-3 fatty acids decrease mortality and Kupffer cell prostaglandin E2 production in a rat model of chronic sepsis. J Trauma (1991) 0.90

Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest (1987) 0.90

Intestinal bacterial flora, intestinal pathology, and lipopolysaccharide-induced translocation of intestinal bacteria. Circ Shock (1992) 0.89

Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin (1993) 0.89

Distribution of proteins in pulmonary edema. The value of fractional concentrations. Am Rev Respir Dis (1987) 0.89

Pancreatic function after normothermic ischemia. II. Cadaveric transplantation. Am J Surg (1970) 0.89

An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology (1995) 0.89

Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer. Gut (2003) 0.89

Anaerobic bioprocessing of organic wastes. World J Microbiol Biotechnol (1996) 0.89